10 research outputs found
Correlates of maternal acceptance (n = 2962) of infant HIV testing (logistic regression).
<p>PEDITEST ANRS 12165 Study, Abidjan, CĂ´te d'Ivoire, 2008.</p><p>OR: Odds Ratio; aOR: Adjusted Odds Ratio. NI: not included.</p
Rate of maternal acceptance and adequate parental acceptance for routine early infant HIV testing (N = 3013).
<p>Rate of maternal acceptance and adequate parental acceptance for routine early infant HIV testing (N = 3013).</p
Flow diagram of the population selection after a universal offer for early infant HIV diagnosis (N = 3013).
<p>Flow diagram of the population selection after a universal offer for early infant HIV diagnosis (N = 3013).</p
Correlates of adequate parental acceptance (n = 2962) of infant HIV testing (logistic regression).
<p>PEDITEST ANRS 12165 Study, Abidjan, CĂ´te d'Ivoire, 2008.</p><p>OR: Odds Ratio; aOR: Adjusted Odds Ratio. NI: Not included.</p
Two-Year Probability of Remaining Free from Validated Morbidity (Diarrhea, Acute Respiratory Infection, or Malnutrition) According to the Feeding Group and Pediatric HIV Status
<p>ANRS 1201/1202 Ditrame Plus Study, Abidjan, Côte d'Ivoire, 2001–2005 (<i>n</i> = 557).</p
Two-Year Probability of Remaining Free from Adverse Health Outcome (Hospitalization or Death or Validated Morbidity) According to the Feeding Group and Pediatric HIV Status
<p>ANRS 1201/1202 Ditrame Plus study, Abidjan, Côte d'Ivoire, 2001–2005 (<i>n</i> = 557).</p
Two-Year Probability of Remaining Free from Severe Events (Hospitalization or Death) According to the Feeding Group and Pediatric HIV Status
<p>ANRS 1201/1202 Ditrame Plus study, Abidjan, Côte d'Ivoire, 2001–2005 (<i>n</i> = 557).</p
Mean costs of care estimated in Abidjan during the first 12-month on LPV/r based ART and per child-month of follow-up.
<p>N = 99. The MONOD ANRS 12206 study.</p
Mean costs per child-month according the Severe Morbid Event (SME) history in HIV-infected children initiating LPV/r–based ART< 24 months of age in Abidjan, Cote d’Ivoire.
<p>The MONOD ANRS 12206 study.</p
Distribution of the 99 children included in the first phase of the MONOD trial in Abidjan, Cote d’Ivoire, according to their mean cost per month of care during the first 12 months of LPV/r-based antiretroviral therapy, stratified by severe morbidity during follow-up (SME).
<p>Distribution of the 99 children included in the first phase of the MONOD trial in Abidjan, Cote d’Ivoire, according to their mean cost per month of care during the first 12 months of LPV/r-based antiretroviral therapy, stratified by severe morbidity during follow-up (SME).</p